Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Lupin Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
500257
INE326A01037
451.6295136
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
LUPIN
36.43
99735.61
EPS(TTM)
Face Value(
)
Div & Yield %:
60.02
2
0.37
Back
S & T Corporation Ltd
S & T Corporation Ltd - Reg. 34 (1) Annual Report.
Aug 22,2024
Pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations. 2015 please find enclosed Annual Report of the Company for the year ended 31st March 2024 along with Notice of 40th Annual General Meeting. Please note that the 40th Annual General Meeting of the Company is scheduled to be held on Friday 13th September 2024 at 3:00 p.m. via Video Conferencing / Other Audio Visual Means as per the relevant Circulars issued by Ministry of Corporate Affairs (MCA) and Securities and Exchange Board of India (SEBI). The Annual Report is also uploaded on the Companys website www.stcl.co.in